Ovarian Cancer Trial, Recruiting (NCT06422455)

Ovarian Cancer Trial, Recruiting NCT06422455 Sponsor: University of Southern California Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06422455 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with at least one of the following: ovarian cancer (epithelial type), pancreatic cancer (exocrine type), prostate cancer that has spread or is considered high or very high risk, breast cancer diagnosed at age 50 or younger, breast cancer in both breasts, triple negative breast cancer, or breast cancer if you are male
OR you are a healthcare provider who treats patients with any of the cancer types listed above
You are able to read and write in English or Spanish
You are able to give your informed agreement to take part in the study

Who may not be able to join:

You are not able to give your informed agreement to take part in the study
You are unable to see, read, or write
You have one of the qualifying cancer diagnoses but do not speak English or Spanish
You do not have any of the cancer diagnoses or characteristics listed above (for patients)
You are a healthcare provider but do not treat cancer patients

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charite Ricker, MS, University of Southern California

Phone: 323-409-7710

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06422455

Sponsor: University of Southern California

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 323-409-7710

More information: https://clinicaltrials.gov/study/NCT06422455

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with at least one of the following: ovarian cancer (epithelial type), pancreatic cancer (exocrine type), prostate cancer that has spread or is considered high or very high risk, breast cancer diagnosed at age 50 or younger, breast cancer in both breasts, triple negative breast cancer, or breast cancer if you are male
OR you are a healthcare provider who treats patients with any of the cancer types listed above
You are able to read and write in English or Spanish
You are able to give your informed agreement to take part in the study

Who may not be able to join:

You are not able to give your informed agreement to take part in the study
You are unable to see, read, or write
You have one of the qualifying cancer diagnoses but do not speak English or Spanish
You do not have any of the cancer diagnoses or characteristics listed above (for patients)
You are a healthcare provider but do not treat cancer patients

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Southern California

Registry

ClinicalTrials.gov

Start date

24 October 2023

Est. completion

24 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of participants who receive genetic testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov